Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
22 Mar 24
DEF 14A
Definitive proxy
22 Mar 24
ARS
2023 FY
Annual report to shareholders
22 Mar 24
8-K
Departure of Directors or Certain Officers
15 Mar 24
PRE 14A
Preliminary proxy
28 Feb 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Janus Henderson Group plc Reports Fourth Quarter and Full-Year 2023 Results
1 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
8-K
Janus Henderson Group plc Reports Third Quarter 2023 Results
1 Nov 23
8-K
Departure of Directors or Certain Officers
18 Aug 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
8-K
Janus Henderson Group plc Reports Second Quarter 2023 Results
2 Aug 23
8-K
Entry into a Material Definitive Agreement
5 Jul 23
8-K
Janus Henderson Announces Changes to Board of Directors
2 Jun 23
8-K
Janus Henderson Announces Appointment of Leslie F. Seidman to Board of Directors
31 May 23
8-K
Submission of Matters to a Vote of Security Holders
5 May 23
10-Q
2023 Q1
Quarterly report
3 May 23
8-K
Janus Henderson Group plc Reports First Quarter 2023 Results
3 May 23
DEFA14A
Additional proxy soliciting materials
24 Mar 23
8-K
Departure of Directors or Certain Officers
24 Mar 23
ARS
2022 FY
Annual report to shareholders
24 Mar 23
DEFA14A
Additional proxy soliciting materials
24 Mar 23
DEF 14A
Definitive proxy
24 Mar 23
PRE 14A
Preliminary proxy
1 Mar 23
10-K
2022 FY
Annual report
28 Feb 23
8-K
Janus Henderson Group plc Reports Fourth Quarter and Full-Year 2022 Results
2 Feb 23
8-K
Janus Henderson announces changes to Board of Directors
15 Nov 22
10-Q
2022 Q3
Quarterly report
31 Oct 22
8-K
Janus Henderson Group plc Reports Third Quarter 2022 Results
27 Oct 22
8-K
Janus Henderson announces changes to Board of Directors
30 Sep 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
8-K
Janus Henderson Group plc Reports Second Quarter 2022 Results
28 Jul 22
8-K
Ali Dibadj joins Janus Henderson as Chief Executive Officer and Director
21 Jun 22
S-8
Registration of securities for employees
16 Jun 22
8-K
Departure of Directors or Certain Officers
15 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
5 May 22
8-K
Regulation FD Disclosure
5 May 22
10-Q
2022 Q1
Quarterly report
4 May 22
8-K
Janus Henderson Group plc Reports First Quarter 2022 Results
4 May 22
8-K
Regulation FD Disclosure
24 Mar 22
Latest ownership filings
3
STEVEN SABA
12 Apr 24
SC 13G
ARCA biopharma, Inc.
11 Apr 24
SC 13G/A
Beauty Health Co
5 Apr 24
SC 13G
PRECISION BIOSCIENCES INC
11 Mar 24
SC 13G
Applied Therapeutics Inc.
8 Mar 24
4
Brennan A. Hughes
7 Mar 24
4
MICHELLE ROSENBERG
4 Mar 24
4
Brennan A. Hughes
4 Mar 24
4
Ali Dibadj
4 Mar 24
4
GEORGINA FOGO
4 Mar 24
4
ROGER MJ THOMPSON
4 Mar 24
4
GEORGINA FOGO
1 Mar 24
4
ROGER MJ THOMPSON
1 Mar 24
4
JAMES R LOWRY
1 Mar 24
SC 13G
Neurogene Inc.
14 Feb 24
SC 13G
Lexeo Therapeutics, Inc.
14 Feb 24
SC 13G
Lantheus Holdings, Inc.
14 Feb 24
SC 13G
IDEAYA Biosciences, Inc.
14 Feb 24
SC 13G
GoDaddy Inc.
14 Feb 24
SC 13G
CymaBay Therapeutics, Inc.
14 Feb 24
SC 13G
CARGO Therapeutics, Inc.
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13G/A
Benitec Biopharma Inc.
14 Feb 24
SC 13G/A
OmniAb, Inc.
13 Feb 24
SC 13G/A
MADRIGAL PHARMACEUTICALS, INC.
13 Feb 24
SC 13G/A
Consensus Cloud Solutions, Inc.
13 Feb 24
SC 13G/A
AVADEL PHARMACEUTICALS PLC
13 Feb 24
SC 13G/A
SOLENO THERAPEUTICS INC
13 Feb 24
SC 13G/A
Larimar Therapeutics, Inc.
13 Feb 24
SC 13G/A
ARDELYX, INC.
13 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
WEX Inc.
13 Feb 24
SC 13G/A
EAGLE PHARMACEUTICALS, INC.
13 Feb 24
SC 13G/A
Walker & Dunlop, Inc.
13 Feb 24
SC 13G/A
OSI SYSTEMS INC
13 Feb 24
SC 13G/A
LIGAND PHARMACEUTICALS INC
13 Feb 24
SC 13G/A
ICU MEDICAL INC/DE
13 Feb 24
SC 13G/A
CONSTELLIUM SE
13 Feb 24
SC 13G/A
CIMPRESS plc
13 Feb 24
SC 13G/A
Beauty Health Co
13 Feb 24